Standex International heads into its May 1 Q3 earnings report with a notable insider selling wave running counter to a stock that has bounced hard off its lows.
The insider picture is the clearest signal. CEO David Dunbar sold 15,000 shares worth roughly $3.84 million in mid-February. The CFO, chief legal officer, chief information officer, and chief strategy officer all followed with additional sales in late March and early April. Net insider selling over the past 90 days totals over $5.65 million. These are modest in the context of each executive's holdings, but the breadth — C-suite and board members alike — gives the cluster some weight heading into the print.
The stock's rebound makes that selling look prescient in reverse. SXI closed at $273, up nearly 8% on the day before the report and 9% higher on the month, even as the broader peer group struggled. Close correlated names like TKR, CAT, and GHM were all down on the week, while fell more than 3%. SXI's outperformance narrows the margin for disappointment at the print.
Short interest tells a relatively contained story, though it has been drifting higher. SI % of free float has climbed to just over 5%, up roughly 6% on the week — a meaningful move, but borrow costs remain negligible at 0.45% and availability has actually eased, suggesting no squeeze dynamic is building. The ORTEX short score at 45.6 sits in the lower half of the universe, consistent with a position that is present but not aggressive. Options positioning has unwound from the defensive extremes seen in March and April, when the put/call ratio ran above 1.3; it has settled back to 1.02, broadly in line with its 20-day average.
On the analyst side, DA Davidson raised its target to $323 on April 20 — the most recent move and the most bullish on the Street. The mean target of $288.80 implies roughly 6% upside from current levels, a thin cushion given the stock's recent run. Bulls point to a diversified product base and strong forward EPS growth — the 12-month forward EPS estimate trajectory ranks in the 97th percentile of the universe. Bears flag macro exposure, particularly China slowdown risk, organic growth questions, and low trading liquidity as structural overhangs. The dividend score ranks in the 98th percentile, which anchors valuation for income-sensitive holders, but the P/E near 30x and EV/EBITDA around 18x leave little room for a miss.
The earnings print will test whether SXI's operational execution justifies a valuation that has rerated sharply higher — even as the people running the business were quietly reducing their exposure.
See the live data behind this article on ORTEX.
Open SXI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
